EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.14.14.19 | 16,17-dehydropregnenolone + [reduced NADPH-hemoprotein reductase] + O2 |
- |
Homo sapiens |
? + [oxidized NADPH-hemoprotein reductase] + H2O |
- |
? |
1.14.14.19 | 16,17-dehydroprogesterone + [reduced NADPH-hemoprotein reductase] + O2 |
- |
Homo sapiens |
? + [oxidized NADPH-hemoprotein reductase] + H2O |
- |
? |
1.14.14.19 | 17alpha-hydroxyprogesterone + AH2 + O2 |
- |
Homo sapiens |
? |
- |
? |
1.14.14.19 | 17alpha-hydroxyprogesterone + AH2 + O2 |
- |
Rattus norvegicus |
? |
- |
? |
1.14.14.19 | 2 progesterone + 2 AH2 + 2 O2 |
- |
Homo sapiens |
17alpha-hydroxyprogesterone + 16alpha-hydroxyprogesterone + 2 A + 2 H2O |
- |
? |
1.14.14.19 | 5alpha-pregnan-3,20-dione + NADPH + O2 |
- |
Homo sapiens |
5alpha-pregnan-17alpha-ol-3,20-dione + NADP+ + H2O |
- |
? |
1.14.14.19 | 5alpha-pregnan-3alpha-ol-20-one + NADPH + O2 |
- |
Homo sapiens |
5alpha-pregnan-3alpha,17alpha-diol-20-one + ? |
- |
? |
1.14.14.19 | 7-dehydropregnenolone + [reduced NADPH-hemoprotein reductase] + O2 |
- |
Homo sapiens |
7-dehydro-17alpha-hydroxypregnenolone + [oxidized NADPH-hemoprotein reductase] + H2O |
- |
? |
1.14.14.19 | a C21-steroid + [reduced NADPH-hemoprotein reductase] + O2 |
- |
Homo sapiens |
a 17alpha-hydroxy-C21-steroid + [oxidized NADPH-hemoprotein reductase] + H2O |
- |
? |
1.14.14.19 | more |
both the lyase and hydroxylase activities proceed from a common steroid-binding geometry by an iron oxene mechanism |
Homo sapiens |
? |
- |
? |